Daiwa Securities Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$88K Buy
1,800
+1,518
+538% +$74.2K ﹤0.01% 1005
2025
Q1
$10K Hold
282
﹤0.01% 1095
2024
Q4
$11K Sell
282
-45
-14% -$1.76K ﹤0.01% 1111
2024
Q3
$15K Buy
327
+30
+10% +$1.38K ﹤0.01% 1113
2024
Q2
$16K Sell
297
-1,080
-78% -$58.2K ﹤0.01% 1133
2024
Q1
$94K Sell
1,377
-88
-6% -$6.01K ﹤0.01% 1046
2023
Q4
$92K Sell
1,465
-198
-12% -$12.4K ﹤0.01% 1022
2023
Q3
$75K Hold
1,663
﹤0.01% 1031
2023
Q2
$93K Buy
1,663
+1,348
+428% +$75.4K ﹤0.01% 1015
2023
Q1
$14K Hold
315
﹤0.01% 1079
2022
Q4
$13K Buy
315
+26
+9% +$1.07K ﹤0.01% 1094
2022
Q3
$19K Hold
289
﹤0.01% 1093
2022
Q2
$18K Sell
289
-1,624
-85% -$101K ﹤0.01% 1111
2022
Q1
$120K Buy
1,913
+530
+38% +$33.2K ﹤0.01% 1018
2021
Q4
$105K Buy
1,383
+548
+66% +$41.6K ﹤0.01% 1000
2021
Q3
$93K Buy
835
+686
+460% +$76.4K ﹤0.01% 995
2021
Q2
$24K Hold
149
﹤0.01% 1008
2021
Q1
$18K Buy
149
+16
+12% +$1.93K ﹤0.01% 1015
2020
Q4
$20K Sell
133
-255
-66% -$38.3K ﹤0.01% 982
2020
Q3
$32K Buy
388
+52
+15% +$4.29K ﹤0.01% 955
2020
Q2
$32K Hold
336
﹤0.01% 937
2020
Q1
$14K Hold
336
﹤0.01% 1022
2019
Q4
$19K Sell
336
-12
-3% -$679 ﹤0.01% 1007
2019
Q3
$14K Buy
348
+16
+5% +$644 ﹤0.01% 1001
2019
Q2
$16K Hold
332
﹤0.01% 1012
2019
Q1
$12K Buy
332
+78
+31% +$2.82K ﹤0.01% 1012
2018
Q4
$7K Hold
254
﹤0.01% 1013
2018
Q3
$11K Hold
254
﹤0.01% 1017
2018
Q2
$15K Hold
254
﹤0.01% 1012
2018
Q1
$12K Buy
+254
New +$12K ﹤0.01% 1007